| dc.creator |
BAS, Hasan Aydin |
|
| dc.creator |
AKSOY, Fatih |
|
| dc.creator |
GULER, Serdar |
|
| dc.creator |
KAHRAMAN, Fatih |
|
| dc.creator |
KUYUMCU, Mevlüt Serdar |
|
| dc.creator |
BAĞCI, Ali |
|
| dc.creator |
UYSAL, Dinçer |
|
| dc.creator |
VAROL, Ercan |
|
| dc.date |
2018-12-31T21:00:00Z |
|
| dc.date.accessioned |
2020-10-06T10:32:57Z |
|
| dc.date.available |
2020-10-06T10:32:57Z |
|
| dc.identifier |
7884b5e8-73ee-4847-adc1-85a2de01e736 |
|
| dc.identifier |
10.21470/1678-9741-2019-0062 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/7884b5e8-73ee-4847-adc1-85a2de01e736/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/63925 |
|
| dc.description |
Introduction: Metabolic syndrome (MetS) is defined as an association between diabetes, hypertension, obesity and dyslipidemia and an increased risk of cardiovascular disease. Mitral annular calcification (MAC) is associated with several cardiovascular disorders, including coronary artery disease, atrial fibrillation (AF), heart failure, ischemic stroke and increased mortality. The CHA(2)DS(2)-VASc score is used to estimate thromboembolic risk in AF. However, the association among MAC, MetS and thromboembolic risk is unknown and was evaluated in the current study. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
The Relationship Between Mitral Annular Calcification, Metabolic Syndrome and Thromboembolic Risk |
|
| dc.type |
info:eu-repo/semantics/article |
|